Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
COPD phenotypes: differences in survival.
Int J Chron Obstruct Pulmon Dis. 2018 Jul 20;13:2245-2251. doi: 10.2147/COPD.S166163. eCollection 2018.
Int J Chron Obstruct Pulmon Dis. 2018.
PMID: 30050297
Free PMC article.
Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes.
Ji Z, Hernández-Vázquez J, Domínguez-Zabaleta IM, Xia Z, Bellón-Cano JM, Gallo-González V, Ali-García I, Matesanz-Ruiz C, López-de-Andrés A, Jiménez-García R, Buendía-García MJ, Gómez-Sacristán Á, Girón-Matute WI, Puente-Maestu L, de Miguel-Díez J.
Ji Z, et al. Among authors: ali garcia i.
Int J Chron Obstruct Pulmon Dis. 2020 Oct 30;15:2759-2767. doi: 10.2147/COPD.S270770. eCollection 2020.
Int J Chron Obstruct Pulmon Dis. 2020.
PMID: 33154636
Free PMC article.
Item in Clipboard
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators.
Harrison TW, et al.
Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22.
Lancet Respir Med. 2021.
PMID: 33357499
Clinical Trial.
Item in Clipboard
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
Montgomery H, Hobbs FDR, Padilla F, Arbetter D, Templeton A, Seegobin S, Kim K, Campos JAS, Arends RH, Brodek BH, Brooks D, Garbes P, Jimenez J, Koh GCKW, Padilla KW, Streicher K, Viani RM, Alagappan V, Pangalos MN, Esser MT; TACKLE study group.
Montgomery H, et al.
Lancet Respir Med. 2022 Oct;10(10):985-996. doi: 10.1016/S2213-2600(22)00180-1. Epub 2022 Jun 7.
Lancet Respir Med. 2022.
PMID: 35688164
Free PMC article.
Clinical Trial.
Item in Clipboard
Differences in Survival of Patients With COPD According to the New GesEPOC 2021 Classification of Phenotypes.
Ji Z, Hernández-Vázquez J, Esteban-Yagüe M, García-Valentín P, Bellón-Cano JM, Domínguez-Zabaleta IM, Ali-García I, Matesanz-Ruiz C, Buendía-García MJ, de Miguel-Díez J.
Ji Z, et al. Among authors: ali garcia i.
Open Respir Arch. 2022 Oct 3;4(4):100212. doi: 10.1016/j.opresp.2022.100212. eCollection 2022 Oct-Dec.
Open Respir Arch. 2022.
PMID: 37496957
Free PMC article.
Item in Clipboard
Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients.
Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM, de Llano LP, Gutiérrez-Pereyra F, Tarragona E, Palomino R, López-Viña A; TAI Study Group.
Plaza V, et al.
J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):142-52. doi: 10.1089/jamp.2015.1212. Epub 2015 Jul 31.
J Aerosol Med Pulm Drug Deliv. 2016.
PMID: 26230150
Free PMC article.
Item in Clipboard
Cite
Cite